IMMUNE RESPONSE IN MALIGNANT GLIOMA
Objective: Malignant gliomas are primary brain tumors with excessive mortality and high resistance to chemotherapy and radiotherapy. The survival time for glioblastoma multiforme is about 6-12 months. As key pathogenetic mechanisms are recognized the massive necrosis, angiogenesis and hypoxia withi...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Peytchinski Publishing
2010-07-01
|
Series: | Journal of IMAB |
Subjects: | |
Online Access: | http://www.journal-imab-bg.org/statii-10/vol16_b3_p17-19.pdf |